FDA Warning Letter — Shriram Institute For Industrial Research
The FDA took a Warning Letter action against Shriram Institute For Industrial Research on Apr 15, 2020 (Delhi, India). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Shriram Institute For Industrial Research
- Date
- Apr 15, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Delhi (India)